BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Start by asking for evidence-based menopausal hormone therapy with FDA‑approved preparations (not “custom” compounded products). In practice that often means estradiol (transdermal patch or low‑dose oral) plus micronized progesterone if you still have a uterus. Ask a clinician who specializes in menopause (NAMS‑certified menopause practitioner, gynecologist or endocrinologist with menopause experience).
• If you still want “BHRT,” insist on FDA‑approved bioidentical products (for example, estradiol and Prometrium [micronized progesterone]) rather than unregulated compounded mixes. If you choose a compounding pharmacy, use a PCAB‑accredited pharmacy and understand the risks.

What “bioidentical” vs “traditional” really means

• “Bioidentical” hormones are chemically identical to human hormones (example: 17β‑estradiol, micronized progesterone). Some FDA‑approved HRT products are bioidentical.
• “Traditional” HRT is a broad term that often refers to older products (conjugated equine estrogens, synthetic progestins such as medroxyprogesterone) and to FDA‑approved regimens.
• The controversial part: “custom compounded BHRT” (made in a compounding pharmacy from a salivary/urine test and dosed uniquely for you) is marketed as safer/more natural, but has little evidence of greater safety or effectiveness and is not FDA‑regulated. Dosing may be inconsistent.

Evidence and safety points you should know

• Major societies (North American Menopause Society, Endocrine Society) recommend FDA‑approved hormone therapy for moderate–severe menopausal symptoms. Use the lowest effective dose for the shortest period needed, and individualize according to risks (VTE, stroke, breast cancer, heart disease).
• Transdermal estradiol (patches) carries lower venous thromboembolism risk than some oral estrogens for people at higher clot risk.
• Micronized progesterone (Prometrium) is often preferred by clinicians who want a “bioidentical” progestogen because of a more favorable side‑effect and possibly breast‑safety profile compared with some synthetic progestins (e.g., medroxyprogesterone acetate/Provera).
• Vaginal low‑dose estrogen products (Vagifem tablets, Estring ring, estradiol creams) are effective for local urogenital symptoms and have minimal systemic absorption.

Specific products/brands to discuss with your clinician

• Estradiol (transdermal patch): Vivelle‑Dot, Climara, Alora — good for hot flashes, lower VTE risk than oral in many studies.
• Oral estradiol: Estrace — an FDA‑approved bioidentical estradiol pill.
• Vaginal/local estrogen: Vagifem (tablet), Estring (ring), Estrace cream — for vaginal dryness, painful intercourse.
• Micronized progesterone: Prometrium — FDA‑approved bioidentical progesterone for endometrial protection if you have a uterus.
• Synthetic progestin examples (traditional): Provera (medroxyprogesterone acetate) — widely used but different effects than progesterone.

When to ask for compounded BHRT — and how to do it safer if you do

• Consider compounded BHRT only after talking through evidence and trying FDA‑approved options or if you have an allergy to an excipient in commercial products, or need a dosage form not available commercially.
• If you go that route: use a PCAB‑accredited compounding pharmacy, ask about batch testing, standardized dosing, liability and whether the prescriber is experienced with compounded hormones. Expect higher cost and likely no insurance coverage.
• Avoid basing dosing on saliva or urine hormone tests; clinicians generally do not recommend these for routine dose titration.

Where to get care

• Best places: a menopause clinic or a clinician with menopause expertise. Look for:
  • A NAMS (North American Menopause Society) Certified Menopause Practitioner or a gynecologist/endocrinologist with a menopause focus.
  • Academic medical centers or established menopause clinics (Mayo Clinic, Cleveland Clinic, major university hospitals often have dedicated programs).
  • Primary care clinicians who have additional menopause training.
• If you choose compounded BHRT, find a reputable compounding pharmacy accredited by PCAB (Pharmacy Compounding Accreditation Board) and a prescriber experienced with compounding.

What to ask your clinician (use as a checklist)

• What are the pros and cons of estradiol vs conjugated estrogens for me?
• Do I need progestogen? If so, can we use micronized progesterone (Prometrium)?
• Is transdermal estradiol a better choice given my clot/heart risk factors?
• Can we try FDA‑approved products first? If not, why?
• If using compounded BHRT, which compounding pharmacy do you recommend and how will dosing be standardized and monitored?
• What monitoring will you do (mammograms, BP, lipids, follow‑up visits), and what side effects should I watch for?
• How long should I expect to use hormones, and what’s the plan for tapering/stopping?

Bottom line recommendation

• Ask first for evidence‑based, FDA‑approved menopausal hormone therapy tailored to your risks and symptoms — commonly estradiol (preferably transdermal if clot risk) and micronized progesterone (Prometrium) if needed.
• If you’re strongly considering “BHRT” beyond FDA products, discuss the limited evidence, and if you still want compounded products, use a PCAB‑accredited pharmacy and a clinician experienced with compounded hormones.

If you want, tell me:

• Your main symptoms, age, whether you still have a uterus, and any major medical history (blood clots, breast cancer, heart disease), and I can suggest more specific options to discuss with a clinician.